Regulation of Experimental Colitis by Enteric Neurons
肠神经元对实验性结肠炎的调节
基本信息
- 批准号:10195754
- 负责人:
- 金额:$ 8.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-15 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAcetylcholineAdolescenceAffectAnti-CholinergicsAnti-Inflammatory AgentsAntiinflammatory EffectAttenuatedAutonomic nervous systemBiological ModelsCell TherapyCell TransplantationCellsChronicColitisColonColonic AganglionosisCongenital MegacolonCrohn&aposs diseaseDevelopmentDiagnosisDigestive System DisordersDiphtheria ToxinDiseaseEnteralEnteric Nervous SystemExhibitsExperimental ModelsFailureGastrointestinal tract structureGoalsHumanImmunomodulatorsImpairmentIndividualInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInjectionsIntestinesInvestigationLengthMediatingMesenchymal Stem CellsModelingMusMyenteric PlexusNerveNeuraxisNeurogliaNeuronsNeurotransmittersOutputPathogenesisPathway interactionsPatientsPlayPredispositionProceduresRegulationResearchRoleSensorySeveritiesSpleenSubmucous PlexusT memory cellTestingTherapeuticTransgenic MiceTransplantationUlcerative Colitisalpha-bungarotoxin receptorautonomic nervebasecholinergiccholinergic neuroncostdiphtheria toxin receptorenteric neuropathyexperimental studygastrointestinal functioninflammatory disease of the intestineinsightmacrophagemouse modelnerve stem cellnerve supplyneurotrophic factornovelnovel therapeutic interventionpostnatalpreventresponseside effectstemstem cell therapystem cellstherapeutic evaluationtherapeutic targettreatment strategyyoung adult
项目摘要
PROJECT SUMMARY
Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn disease, is a chronic and
progressive inflammatory disorder of the gastrointestinal (GI) tract most often diagnosed in
adolescence and young adulthood. While significant progress has been made, current treatments
for IBD are still often unsatisfactory, associated with long-term failure and side effects.
Investigation into the underlying pathogenesis and mechanisms of this condition are warranted to
identify new targets to develop novel treatment strategies. The autonomic nervous system
regulates key functions of the GI tract, including both intrinsic (enteric nervous system, ENS) and
extrinsic (sympathetic and parasympathetic) control of the intestine. Abnormalities of autonomic
nerve function have been described in patients with IBD and several studies suggest that the ENS
may play a role in the development and severity of intestinal inflammation. Acetylcholine (ACh)
from extrinsic parasympathetic nerves is known to have an anti-inflammatory effect on the gut via
the cholinergic anti-inflammatory pathway (CAIP). However, it is unknown whether ACh or other
neurotransmitters derived from the neurons of the ENS have a similar role. In preliminary
experiments, we find that the severity of experimentally induced colitis is worse in regions of focal
ENS ablation. Therefore, we hypothesize that the intrinsic neurons of the ENS can exert an anti-
inflammatory effect in the colon and that this can be leveraged for therapeutic applications. To
test this, we propose the following aims: (1) to determine the mechanisms by which intrinsic
enteric neurons attenuate inflammation in experimental colitis and to (2) examine whether ENS
cell transplantation can reduce inflammation in a mouse model of IBD. We will utilize a novel IBD
mouse with colonic aganglionosis that we recently developed by local injection of human
diphtheria toxin (DT) into transgenic mice that express DT receptor in the ENS. Focal ablation of
either all enteric neurons or the cholinergic enteric neurons will be followed by induction of colitis
to determine the anti-inflammatory roles of the ENS (Aim 1). We will then purify enteric neuronal
stem cells, enteric neurons, and enteric cholinergic neurons and transplant these into recipient
mice with focal colonic aganglionosis following induction of colitis. The impact of cell therapy on
the severity of inflammation will be examined (Aim 2). The results obtained will provide new
insights into the anti-inflammatory role of the ENS and identify new strategies for treating IBD.
项目概要
炎症性肠病(IBD),包括溃疡性结肠炎和克罗恩病,是一种慢性、慢性疾病。
进行性胃肠道 (GI) 炎症性疾病最常诊断为
青春期和青年期。虽然已经取得了重大进展,但目前的治疗方法
IBD 的治疗效果仍然常常不令人满意,与长期失败和副作用相关。
有必要调查这种情况的潜在发病机制和机制
确定新目标以制定新的治疗策略。自主神经系统
调节胃肠道的关键功能,包括内在功能(肠神经系统,ENS)和
肠道的外在(交感神经和副交感神经)控制。自律神经异常
IBD 患者的神经功能已被描述,多项研究表明 ENS
可能在肠道炎症的发生和严重程度中发挥作用。乙酰胆碱 (ACh)
已知来自外在副交感神经的物质对肠道具有抗炎作用
胆碱能抗炎途径(CAIP)。然而,尚不清楚是否是 ACh 或其他
来自 ENS 神经元的神经递质也具有类似的作用。在初步
实验中,我们发现实验诱发的结肠炎的严重程度在局灶性区域更严重
ENS 消融。因此,我们假设 ENS 的内在神经元可以发挥抗-
结肠中的炎症效应,这可以用于治疗应用。到
对此进行测试,我们提出以下目标:(1)确定内在机制
肠神经元减轻实验性结肠炎中的炎症并(2)检查 ENS 是否
细胞移植可以减轻 IBD 小鼠模型的炎症。我们将利用一种新型 IBD
患有结肠无神经节细胞病的小鼠,我们最近通过局部注射人
将白喉毒素 (DT) 注入在 ENS 中表达 DT 受体的转基因小鼠中。局灶消融
所有肠神经元或胆碱能肠神经元都会诱发结肠炎
确定 ENS 的抗炎作用(目标 1)。然后我们将纯化肠神经元
干细胞、肠神经元和肠胆碱能神经元并将它们移植到受体体内
诱发结肠炎后患有局灶性结肠无神经节细胞病的小鼠。细胞治疗的影响
将检查炎症的严重程度(目标 2)。所获得的结果将提供新的
深入了解 ENS 的抗炎作用并确定治疗 IBD 的新策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ryo Hotta其他文献
Ryo Hotta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ryo Hotta', 18)}}的其他基金
Regulation of Experimental Colitis by Enteric Neurons
肠神经元对实验性结肠炎的调节
- 批准号:
10393593 - 财政年份:2021
- 资助金额:
$ 8.26万 - 项目类别:
Autologous cell transplantation for the treatment of colorectal aganglionosis
自体细胞移植治疗结直肠无神经节细胞病
- 批准号:
10308113 - 财政年份:2020
- 资助金额:
$ 8.26万 - 项目类别:
相似国自然基金
基于芋螺毒素肽RgIA的α9α10烟碱型乙酰胆碱受体降解剂用于神经性疼痛治疗
- 批准号:22307083
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
乙酰胆碱-巨噬细胞神经免疫轴在肿瘤运动康复中的作用及机制研究
- 批准号:82303930
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
烟碱型乙酰胆碱受体变异介导普通大蓟马对多杀菌素抗性机制研究
- 批准号:32360663
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
神经肽Y-Y1受体与α7烟碱型乙酰胆碱受体交互作用减轻急性肺损伤的机制研究
- 批准号:82300019
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
慢性应激诱导肺上皮分泌乙酰胆碱重塑乳腺癌肺转移前微环境的机制研究
- 批准号:82303386
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Neurobiological mechanisms of Western diet-induced cognitive dysfunction
西方饮食诱发认知功能障碍的神经生物学机制
- 批准号:
10536310 - 财政年份:2022
- 资助金额:
$ 8.26万 - 项目类别:
Neurobiological mechanisms of Western diet-induced cognitive dysfunction
西方饮食诱发认知功能障碍的神经生物学机制
- 批准号:
10730548 - 财政年份:2022
- 资助金额:
$ 8.26万 - 项目类别:
Regulation of Experimental Colitis by Enteric Neurons
肠神经元对实验性结肠炎的调节
- 批准号:
10393593 - 财政年份:2021
- 资助金额:
$ 8.26万 - 项目类别:
Mitochondrial oxidative stress: a target for treatment of doxorubicin-associated vascular endothelial dysfunction
线粒体氧化应激:治疗阿霉素相关血管内皮功能障碍的靶点
- 批准号:
9909393 - 财政年份:2020
- 资助金额:
$ 8.26万 - 项目类别:
Adolescent Alcohol in 5xFAD Mouse Model Accelerates Neuroinflammation and Alzheimer's Disease Pathology Across Aging
5xFAD 小鼠模型中的青少年酒精会加速衰老过程中的神经炎症和阿尔茨海默病病理学
- 批准号:
10435555 - 财政年份:2020
- 资助金额:
$ 8.26万 - 项目类别: